1 / 4

Horizons-AMI-final 3 year results

Horizons-AMI-final 3 year results.

hadley-fowler
Télécharger la présentation

Horizons-AMI-final 3 year results

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Horizons-AMI-final 3 yearresults Objective: to evaluate the effectiveness and safety of heparin plus GP IIB/IIIA vs bivalirudinand (1:1) paclitaxel-elutingstents vs bare-metalstents (3:1)Study: prospective, open-label randomised trialPopulation: patients >18 years, with ST-segment MI within 12h afteronset of symptomsundergoing PCIEndpoint: MACE at 3 years

  2. Horizons-AMI-final 3 yearresults

  3. Horizons-AMI-final 3 yearresults

  4. Horizons-AMI-final 3 yearresults Conclusion the safety and efficacy of bivalirudinissuperior to heparin plus GP IIB/IIIA at 3 years, and Paclitaxel has lower rate of targetlesionrevascularization Stone Lancet 2011;377:2193-204

More Related